Deutsch

COVID-19: Прививки​

15.06.21 13:09
Re: COVID-19: Прививки​
 
Van Doren коренной житель
Van Doren

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial


  • 93% efficacy against predominantly circulating Variants of Concern and Variants of Interest
  • 91% efficacy in high-risk populations
  • 100% efficacy against variants "not considered Variants of Concern/Interest"
  • All COVID-19 hospitalizations/death occurred in the placebo group
 

Перейти на